Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer
JAMA Oncol
.
2020 Mar 1;6(3):439.
doi: 10.1001/jamaoncol.2019.5677.
Authors
Garvit Chitkara
1
,
Rohini Hawaldar
1
,
Rajendra A Badwe
1
Affiliation
1
Breast Disease Management Group, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
PMID:
31855227
DOI:
10.1001/jamaoncol.2019.5677
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers, Tumor
Breast Neoplasms*
Circulating Tumor DNA*
Humans
Neoplasm Recurrence, Local
Substances
Biomarkers, Tumor
Circulating Tumor DNA